Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-05-31
2011-05-31
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S001800, C514S021200, C530S328000, C530S324000, C424S222100
Reexamination Certificate
active
07951781
ABSTRACT:
Embodiments include compositions and methods for lower the surface tension of a liquid-air interface by contacting such interface with all or part of a PLUNC polypeptide.
REFERENCES:
patent: 2001/0003599 (2001-06-01), Chinn et al.
patent: 2003/0180303 (2003-09-01), Gazzano-Santoro et al.
patent: 2003/0194377 (2003-10-01), Carroll et al.
patent: 2004/0142891 (2004-07-01), Groot et al.
patent: 2005/0181375 (2005-08-01), Aziz et al.
patent: 2005/0192221 (2005-09-01), McCray et al.
patent: 2006/0035852 (2006-02-01), Sahin et al.
patent: 2006/0078506 (2006-04-01), Niven et al.
patent: 2006/0194728 (2006-08-01), Killian et al.
patent: 0100910 (1984-02-01), None
patent: 0110498 (1984-06-01), None
patent: 0119056 (1984-09-01), None
patent: 0145005 (1985-06-01), None
patent: 0251449 (1988-01-01), None
patent: 0286011 (1988-10-01), None
patent: 0348967 (1990-01-01), None
patent: 0368823 (1990-05-01), None
patent: 0593094 (1994-04-01), None
patent: WO 86/03408 (1986-06-01), None
patent: WO 87/06943 (1987-11-01), None
patent: WO 88/03170 (1988-05-01), None
patent: WO 89/04326 (1989-05-01), None
patent: WO 91/00871 (1991-01-01), None
patent: WO 91/18015 (1991-11-01), None
patent: WO 92/22315 (1992-12-01), None
patent: WO 93/06228 (1993-04-01), None
patent: WO 95/32992 (1995-12-01), None
patent: WO 00/08206 (2000-02-01), None
patent: WO 01/36478 (2001-05-01), None
patent: WO 01/79492 (2001-10-01), None
patent: WO 03/087143 (2003-10-01), None
patent: WO 03/087143 (2003-10-01), None
patent: WO 2005/056045 (2005-06-01), None
Beamer et al., “Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution,”Science, 276:1861-1864, 1997.
Beamer et al., “The BPI/LBP family of proteins: a structural analysis of conserved regions,”Protein Sci., 7:906-914, 1998.
Beamer et al., “The three-dimensional structure of human bactericidal/permeability-increasing protein: implications for understanding protein-lipopolysaccharide interactions,”Biochem. Pharmacol., 57:225-229, 1999.
Beeley et al., “Isolation and characterization of latherin, a surface-active protein from horse sweat,”Biochem J.235:645-50, 1986.
Bingle and Bingle, “Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern,”Biochim. Biophys. Acta, 1493:363-367, 2000.
Bingle and Craven, “PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx,”Hum. Molec. Genet., 11:937-943, 2002.
Bone, “The pathogenesis of sepsis,”Annals Int Med, 115:457-469, 1991.
Bruce et al., “The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein,”Curr. Opin. Struct. Biol., 8:426-434, 1998.
Campos et al., “Purification and characterization of PLUNC from human tracheobronchial secretions,”Am. J. Respir. Cell Mol. Biol., 30:184-192, 2004.
Database NCBI, “Burkholderia sp. 383,” Database Accession No. ABB08889, Oct. 20, 2005.
Database NCBI, “Homo sapiens(human),” Database Accession No. AAF70860, Oct. 2, 2000.
Database NCBI, “Homo sapiens(human),” Database Accession No. AAM00283, Apr. 2, 2002.
Database NCBI, “Homo sapiens(human),” Database Accession No. CAC03546, Jan. 6, 2005.
Database NCBI, “Homo sapiens(human),” Database Accession No. CAC18884, Jan. 7, 2005.
Database NCBI, “Homo sapiens(human),” Database Accession No. CAC18886, Feb. 19, 2001.
Database NCBI, “Homo sapiens(human),” Database Accession No. NP—848561, Oct. 27, 2004.
Database NCBI, “Homo sapiens(human),” Database Accession No. CAC18887, Feb. 19, 2001.
Database NCBI, “Homo sapiens(human),” Database Accession No. NM—016583, Jun. 1, 2008.
Database NCBI, “Homo sapiens(human),” Database Accession No. P59827, Jun. 10, 2008.
Database NCBI, “Homo sapiens(human),” Database Accession No. P59826, Jun. 10, 2008.
Davies et al., “Comparative pharmacokinetics of cefamandole, cefurozxime and cephradine during total hip replacement,”J Antimicrob Chemother, 7(5):637-640, 1986.
Dear et al., “Novel genes for potential ligand-binding proteins in subregions of the olfactory mucosa,”EMBO J., 10, 2813-2819, 1991.
Elsbach and Weiss, “Role of the bactericidal/permeability-increasing protein in host defence,”Curr. Opin. Immunol., 10:45-49, 1998.
Ganz, “Antimicrobial polypeptides,”J. Leukocyte Biology, 74:34-38, 2004.
GenCore version 5.1.7, result 1, pp. 1-2, Feb. 24, 2006.
Ghafouri et al., “Comparative proteomics of nasal fluid in seasonal allergic rhinitis,”J. Proteome Res., 5:330-338, 2006.
Ghafouri et al., “Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting,”Proteomics, 2:112-120, 2002.
Ghafouri et al., “PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide,”Biochim Biophys Acta.1699:57-63, 2004.
Giardina et al., “Construction of acetate auxotrophs ofNeisseria meningitidisto study host-meningococcal endotoxin interactions,”J Biol Chem, 276:5883-5891, 2001.
Goubran Botros et al., “Biochemical characterization and surfactant properties of horse allergens,”European J. Biochemistry/FEBS, 268(10): 3126-3136, 2001.
Huuskonen et al., “Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis,”J. Lipid Res., 40:1123-1130, 1999.
Hwang and Vogel, “Structure-function relationships of antimicrobial peptides,”Biochem Cell Biol, 76(2-3):235-246, 1998.
Kelley et al., “Enhanced genome annotation using structural profiles in the program 3D-PSSM,”J. Mol. Biol., 299:499-520, 2000.
Kleiger et al., “The 1.7 A crystal structure of BPI: a study of how tow dissimilar amino acid sequences can adopt the same fold,”J Mol Biol, 299:1019-1034, 2000.
LeClair et al., “Genomic organization of the mouse plunc gene and expression in the developing airways and thymus,”Biochem. Biophys. Res. Commun., 284:792-797, 2001.
LeClair et al., “TPL, a mouse member of the PLUNC protein family expressed in tongue epithelium,”Genomics, 2002.
Leclair, “Four BPI (bactericidal/permeability-increasing protein)-like genes expressed in the mouse nasal, oral, airway and digestive epithelia,”Biochem. Soc. Trans., 31:801-805, 2003.
LeClair, “Four reasons to consider a novel class of innate immune molecules in the oral epithelium,”J. Dent. Res., 82:944-950, 2003.
Levy, “A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein,”Antimicrob. Agents Chemother., 44:2925-2931, 2000.
Lindahl et al., “Identification of a new potential airway irritation marker, palate lung nasal epithelial clone protein, in human nasal lavage fluid with two-dimensional electrophoresis and matrix-assisted laser desorption/ionization-time of flight,”Electrophoresis, 22:1795-1800, 2001.
Morrison and Ulevitch, “The effects of bacterial endotoxins on host mediation systems,”Am J Pathol, 93:527-617, 1978.
Reynolds, In:Integrated host defense against infections, Crystal et al. (Eds.), The Lung, 2ndEd., NY, Raven Press, Ltd., 2353-2365, 1997.
Roxo-Rosa et al., “Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease,”Proteomics, 6:2314-2325, 2006.
Sande et al., “Intermittent or continuous therapy of experimental meningitis due toStreptococcus pneumoniaein rabbits: preliminary observations on the postantibiotic effect in vivo,”Rev Infect Dis, 3(1):98-109, 1981.
S
Bartlett Jennifer
Gakhar Lokesh
Mallampalli Rama K.
McCray, Jr. Paul B.
Ramaswamy Subramanian
Fulbright & Jaworski
Gudibande Satyanarayana R
Tsang Cecilia
University of Iowa Research Foundation
LandOfFree
Methods and compositions related to PLUNC surfactant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions related to PLUNC surfactant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions related to PLUNC surfactant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2645462